Cerebrospinal fluid levels of quinolinic acid in Huntington's disease and schizophrenia
- 8 October 1988
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 24 (4) , 580-582
- https://doi.org/10.1002/ana.410240417
Abstract
The concentration of the endogenous excitotoxin quinolinic acid was determined in the cerebrospinal fluid of drug‐free patients suffering from Huntington's disease or schizophrenia (control group). In both diseases, quinolinic acid concentrations were highly variable (< 4–48 nM) but the mean levels for each disease group were not significantly different from each other or from the quinolinic acid concentration of normal cerebrospinal fluid. Analysis of steady‐state cerebrospinal fluid quinolinic acid concentration is unlikely to be of value as a diagnostic tool in Huntington's disease.This publication has 5 references indexed in Scilit:
- Increase in the Content of Quinolinic Acid in Cerebrospinal Fluid and Frontal Cortex of Patients with Hepatic FailureJournal of Neurochemistry, 1986
- A radioenzymatic assay for quinolinic acidAnalytical Biochemistry, 1986
- II. Excitotoxic models for neurodegenerative disordersLife Sciences, 1984
- Studies on the disposition of quinolinic acid after intracerebral or systemic administration in the ratExperimental Neurology, 1984
- Huntington diseaseNeurology, 1979